Log in to save to my catalogue

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abc567933a9640a2aa8229af8855b074

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients

About this item

Full title

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2022-12, Vol.14 (12), p.2786

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: Cefiderocol is a siderophore cephalosporin antibiotic active against Gram-negative bacteria, including extended-spectrum beta-lactamase and carbapenemase-producing strains. The pharmacokinetics of cefiderocol has been studied in healthy subjects and particularly in phase II and III studies. This retrospective study investigated intraven...

Alternative Titles

Full title

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_abc567933a9640a2aa8229af8855b074

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abc567933a9640a2aa8229af8855b074

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14122786

How to access this item